U.S. Residential REITs Stock News

Greene County Bancorp (GCBC) opened Q2 2026 with total revenue of US$22.0 million and basic EPS of US$0.60, while trailing twelve month figures show revenue of US$82.0 million and EPS of US$2.15, alongside earnings growth of 37.4% over the last year. Over recent quarters, the company has seen revenue move from US$17.5 million and EPS of US$0.44 in Q2 2025 to US$22.0 million and EPS of US$0.60 in Q2 2026. The trailing net profit margin stands at 43.6% versus 38.3% last year, setting up an...

On January 8, 2026, Sempra announced that David J. Barrett will become Senior Vice President and Deputy General Counsel of Litigation and Regulatory for Sempra, stepping down as Senior Vice President and General Counsel at SoCalGas effective January 31, 2026. This leadership shift comes just ahead of Sempra’s upcoming fiscal fourth-quarter earnings release, where analysts are projecting a year-over-year profit decline. Next, we’ll examine how Barrett’s new litigation and regulatory role,...

If you are wondering whether Americold Realty Trust is attractively priced today or simply appears cheap on the surface, this article walks through the key facts so you can assess the value case yourself. The share price last closed at US$13.18, with a 6.5% return over 30 days, a 34.9% decline over 1 year, and a 54.6% decline over 5 years, which may have influenced how the market views its risk and potential. Recent coverage around Americold has focused on its role in temperature controlled...

Leggett & Platt (NYSE:LEG) rejected an unsolicited acquisition proposal from Somnigroup as undervalued. The two companies have signed a non disclosure agreement and standstill to allow Somnigroup to conduct due diligence. Discussions are ongoing regarding a potential transaction, with no final terms agreed. Leggett & Platt enters these talks with a mixed recent track record in the market. The shares last closed at $12.59, with the stock up 14.7% over the past 30 days and 18.9% over the past...

Why Amplitude Is On Investors’ Radar Today Amplitude (AMPL) has been drawing attention after a stretch of negative returns over the past month and year, prompting investors to reassess how its current share price lines up with its fundamentals. The stock last closed at US$9.83, with recent data showing a 1 day return of roughly 1%, a 7 day decline of about 6%, a month slide of around 14%, and a past 3 months move that is close to flat. See our latest analysis for Amplitude. With the share...

Genworth Financial’s subsidiary CareScout has expanded its aging and long-term care platform nationwide, offering families personalized nurse-created care plans and access to a credentialed home care provider network through the CareScout Quality Network. This move positions CareScout as a more comprehensive, one-stop resource for families seeking clearer guidance and vetted in-home support as care needs become more complex. We’ll now examine how CareScout’s nationwide expansion and enhanced...

Why Establishment Labs Holdings (ESTA) just grabbed investors’ attention Establishment Labs Holdings (ESTA) updated the market with preliminary, unaudited revenue guidance for the fourth quarter and full year 2025, highlighting expected contributions from Motiva implant sales in the United States. See our latest analysis for Establishment Labs Holdings. At a share price of $64.63, Establishment Labs has recently seen a 13.15% 1 month share price decline. However, its 90 day share price return...

Eve Holding (EVEX) is back in focus after its subsidiary EVE UAM secured a $150 million syndicated credit facility from international banks, aimed at funding core urban air mobility development and commercialization efforts. See our latest analysis for Eve Holding. The latest $150 million credit facility comes after a mixed stretch for the stock, with a 30 day share price return of a 6.67% decline, a 90 day share price return of 2.05% and a 1 year total shareholder return of a 9.31% decline...

Savers Value Village, Inc. recently reported preliminary results showing fourth-quarter net sales of US$464.7 million and fiscal 2025 net sales of US$1.68 billion, with growth supported by an extra 53rd week and higher comparable store sales. Alongside this sales expansion, the company completed share repurchases totaling about US$57.36 million under two programs, signaling management’s confidence in its own stock. We’ll now examine how this combination of strong comparable store sales...

Gold Resource Corporation reported a past fourth‑quarter 2025 operational turnaround at its Don David Gold Mine, with higher‑grade ore from the Three Sisters area driving record silver sales and a shift toward silver‑weighted production. This operational improvement marks a meaningful change in the company’s revenue mix, increasing its exposure to silver‑linked performance at the Don David operation. We’ll now look at how this operational turnaround and Three Sisters’ higher‑grade ore shape...

If you are wondering whether Power Integrations is attractively priced or still has work to do before looking compelling, its recent price moves and valuation checks give you some useful clues. The share price last closed at US$42.90, with returns of 4.9% over the past week and 17.3% over the past month. The year to date return is 15.0% and the 1-year return is a 30.9% decline. Recent coverage has focused on how Power Integrations fits into the wider semiconductor space and how investors are...

If you are wondering whether Fresh Del Monte Produce at around US$37.30 still offers value, it helps to look past the headline price and focus on what the market is actually paying for its cash flows and assets. The stock has returned 2.0% over the last 7 days, 5.6% year to date and 21.9% over the past year, with a 51.8% return over 3 years and 72.5% over 5 years. This gives useful context before weighing up what that current price might imply. Recent coverage has focused on Fresh Del Monte...

Dave (NasdaqGM:DAVE) has appointed Nima Khajehnouri, Meta’s VP of Engineering, to its Board of Directors. The move brings additional AI and data engineering expertise to the company during an ongoing board reshuffle. The appointment is part of Dave’s push to deepen its technical leadership in the neobanking space. For you as an investor, this board change comes at a time when Dave’s stock has seen sharp moves. Shares recently closed at $185.27, with a 1 year return of 103.8% and a 3 year...

Earlier this week, Reliance Industries reported Q3 results that grew revenue but missed market expectations, as retail EBITDA growth slowed and margins eased while the oil and gas segment saw declines in revenue and EBITDA. Despite solid contributions from Jio Platforms and the oil-to-chemicals business, investor attention has focused on how competitive pressures and higher costs are reshaping the profitability profile of Reliance’s retail operations. Next, we’ll explore how the earnings...

If you are trying to work out whether NextDecade's current share price still reflects its long term potential, the key question is how the stock stacks up against its underlying value. The share price closed at US$4.86 recently, after a 7.4% decline over the last week and a 11.3% decline over the last month, with the one year return at a 46.3% loss and the five year return at 78.7%. Recent news around NextDecade has focused on its role in US liquefied natural gas projects and its efforts to...

If you are wondering whether SLM's share price still reflects good value after its long run as a student lending name, you are not alone. The stock last closed at US$26.00, with returns of a 3.1% decline over 7 days, a 4.9% decline over 30 days, a 5.1% decline year to date, and a 7.4% decline over 1 year. The 3 year and 5 year returns sit at 65.1% and 120.9% respectively. Recent coverage has focused on how SLM fits into the broader student loan and consumer credit conversation, with...

Edgewise Therapeutics (EWTX) updated investors on its late stage pipeline, outlining 2026 milestones for muscular dystrophy and cardiovascular programs. These include key sevasemten trial readouts and a potential future New Drug Application submission. See our latest analysis for Edgewise Therapeutics. The update on 2026 clinical milestones comes as Edgewise Therapeutics trades at $28.73, with a 90 day share price return of 92.95% and a 3 year total shareholder return of 160.24%. This...

If you are wondering whether VeriSign's share price still reflects fair value or if expectations have run ahead of the fundamentals, you are in the right place. VeriSign shares most recently closed at US$248.12, with returns of 0.7% over the last 7 days, 1.7% over the last 30 days, 3.2% year to date and 18.9% over 1 year, while the 3 and 5 year returns sit at 16.1% and 27.7% respectively. These price moves sit against a backdrop of ongoing attention on domain infrastructure providers and the...

If you are wondering whether Paycom Software's current share price lines up with its underlying value, you are not alone. This article is built to help you size that up clearly. The stock closed at US$147.48, with returns of a 6.4% decline over 7 days, a 9.4% decline over 30 days, a 3.2% decline year to date and a 29.0% decline over 1 year, alongside a 53.0% decline over 3 years and a 61.6% decline over 5 years, which may have shifted how investors view its risk and potential reward. Recent...

If you are looking at Qorvo and wondering whether the current share price reflects fair value or an opportunity, you are not alone. The stock last closed at US$79.85, with returns of a 0.5% decline over 7 days, a 6.8% decline over 30 days, a 7.4% decline year to date and an 8.8% decline over 1 year, alongside longer term returns of a 26.1% decline over 3 years and a 54.4% decline over 5 years. Recent attention on Qorvo has centered on how these share price moves fit with its position in the...

Option Care Health (OPCH) has drawn fresh attention after expanding its share repurchase authorization to US$1b, completing earlier buybacks, and issuing full year 2026 net revenue guidance of US$5.8b to US$6.0b. See our latest analysis for Option Care Health. Those announcements come after a strong run in the share price, with a 30 day share price return of 10.09% and a 90 day share price return of 26.51%, while the 1 year total shareholder return of 21.45% and 5 year total shareholder...

Earlier this month, National Vision Holdings, Inc. reaffirmed its earnings guidance for the 53 weeks ended January 3, 2026, maintaining expected net revenue between US$1.97 billions and US$1.99 billions. This confirmation of the revenue outlook reinforces management’s confidence in the company’s operating trajectory and offers investors increased clarity on near-term expectations. Next, we’ll examine how National Vision’s decision to reaffirm full-year earnings guidance shapes the company’s...

As the United States market experiences a rebound following recent volatility, with major indices like the Dow Jones and S&P 500 showing significant gains after addressing geopolitical tensions, investors are keeping a close eye on high-growth sectors. In this dynamic environment, identifying tech stocks with strong fundamentals and innovative potential can be crucial for navigating the opportunities presented by such market fluctuations.

Amid recent volatility in the U.S. markets, with major indices like the Dow Jones and S&P 500 experiencing significant fluctuations due to geopolitical tensions and economic policy shifts, investors are keenly observing opportunities that may arise from these movements. In such an environment, identifying stocks that are potentially undervalued based on intrinsic value estimates can offer a strategic advantage, as they might provide growth potential when market conditions stabilize.